GnRH agonist for postpartum contraception: Biochemical, hormonal and endometrial effects
Tóm tắt
Objective: To determine whether GnRH agonist administration induces changes in biochemical, hormonal and endometrial parameters in breastfeeding women.
Design and patients: Starting at 6 weeks postpartum, fully breastfeeding mothers began treatment with GnRH agonist, receiving 300 μg and 600 μg per day by nasal spray for 6 months. A third group of breastfeeding women who were users of IUDs served as controls. Eighteen biochemical analyses were quantified in serum. Blood samples were collected at 0, 3 and 6 months after treatment and endometrial biopsies were obtained at 0 and 6 months. No other method of contraception was employed.
Results: Interindividual and intergroup differences were observed in clinical chemistry. According to the hormonal levels and the histopathologic analysis, various grades of follicular activity were found in the treated groups. No pregnancies occurred.
Conclusion: Because GnRH agonist treatment had no significant deleterious effects on the parameters studied, this treatment could represent a feasible and safe approach to postpartum contraception.
Tài liệu tham khảo
HowiePW, McNeillyAS. Effects of breast feeding patterns on human birth interval. J Reprod Fertil. 1982;65:545–57.
McNeillyAS, GlasierAF, HowiePW, HoustonMJ, CookA, BoyleH. Fertility after childbirth: pregnancy associated with breast feeding. Clin Endocrinol. 1981;18:167–73.
GuptaA, MathurV, GragSK. Effect of oral contraceptives on quality and quantity of milk secretion in human beings. Indian J Med Res. 1974;62:964.
CroxatoH, DiazS, PeraltaO et al. Fertility regulation in nursing women. IV. Long term influence of low dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception. 1983;27:13.
FraserHM, DewartPJ, SmithSK, CowenGM, SandowJ, McNeillyAS. Luteinizing hormone releasing hormone agonist for contraception in breast feeding women. J Clin Endocrinol Metab. 1989;69:996–1002.
MayagoitiaSB, Hernández MoralesC, TrujilloAMT, VegaRR. Luteinizing hormone releasing hormone agonist for postpartum contraception. Adv Contracept. 1996;12:27–41.
FraserHM. GnRH analogues for contraception. Br Med Bull. 1993;49:62–72.
LemayA, JeanC, FureN. Endometrial history during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progesterone as an antiovulatory contraceptive approach. Fertil Steril. 1987;48:775–82.
Schmidt-GollwitzerM, HardtW, Schmidt-GollwitzerK, von deOheM, Nevinny-StickelJ. Influence of the LHRH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control? Contraception. 1983;23:187–92.
HayslipCC, KleinTA, DunvanWE. The effects of lactation on bone mineral content in healthy postpartum women. Obstet Gynecol. 1989;73:588–93.
ChanGM, DonaldN, SlaterP, HollisJ, ThomasM. Decreased bone mineral status in lactating adolescent mothers. J Pediatr. 1981;101:167–82.
ReynoldsRD, ArcharyaS, LeklemJE, MoserPB. Effects of low maternal dietary intake of calcium, selenium and vitamin B-6 upon breast milk composition. In: HmoshH, GoldmanA, eds. Human lactation. New York: Plenum Press; 1986:205.
ZinamanMJ, HickeyM, TomaiTP, AlbertsonBD, SimonJA. Calcium metabolism in postpartum lactation: the effect of estrogen status. Fertil Steril. 1990;54:465–9.
FogelmanI. Gonadotropin-releasing hormone agonist and the skeleton. Fertil Steril. 1992;57:715–24.
Hoechst. Information, New Products. Bereich Pharma IV/80 HOE 766F (Buserelin/Busereline) LH-RH Analogue.
Sufi BS, Donaldson A, Jeffocoate SL. Programme for Provision of Matched Assay Reagents for the Radioimmunoassay of Hormones in Reproductive Physiology. WHO Special Programme of Research Development and Training in Human Reproduction. Method Manual, 16th edn, January 1992.
FarishE, FletcherCD, BarnesJF, MackA, GrayCE, HartDM. Reversible menopause induced by GnRH analogue Buserelin. Effects on lipoprotein metabolism. Acta Endocrinol. 1992;127:123–6.
FilicoriM, FlamigniG, DellaiP, ArnoneR, FalboA, CapelliM. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women. J Clin Endocrinol Metab. 1993;77:130–3.
SowersM, CortonG, ShapiroB et al. Changes in bone density with lactation. J Am Med Assoc. 1993;269:3130–5.
RicoH, ArnanzF, RevillaM et al. Total and regional bone mineral content in women treated with GnRH agonists. Calcified Tiss Int. 1993;52:354–7.